{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:10:11Z","timestamp":1790536211017,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T00:00:00Z","timestamp":1554940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["RG65966"],"award-info":[{"award-number":["RG65966"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center of Immunodeficiencies Amsterdam"},{"name":"MRC Clinician Scientist Fellowship","award":["MR\/L006197\/1"],"award-info":[{"award-number":["MR\/L006197\/1"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.clim.2019.03.010","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T22:25:05Z","timestamp":1554330305000},"page":"23-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Pathogenic NFKB2 variant in the ankyrin repeat domain (R635X) causes a variable antibody deficiency"],"prefix":"10.1016","volume":"203","author":[{"given":"Paul","family":"Tuijnenburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Lango Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godelieve J.","family":"de Bree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinisa","family":"Savic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machiel H.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Stockdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Simeoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ineke J.M.","family":"ten Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester M.M.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Thaventhiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taco W.","family":"Kuijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2019.03.010_bb0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2019.03.010_bb0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2019.03.010_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","article-title":"The 2017 IUIS phenotypic classification for primary Immunodeficiencies","volume":"38","author":"Bousfiha","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2019.03.010_bb0020","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ajhg.2013.09.009","article-title":"Germline mutations in NFKB2 implicate the noncanonical NF-kappaB pathway in the pathogenesis of common variable immunodeficiency","volume":"93","author":"Chen","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2019.03.010_bb0025","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s10875-014-0064-x","article-title":"Novel NFKB2 mutation in early-onset CVID","volume":"34","author":"Liu","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2019.03.010_bb0030","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s10875-014-0095-3","article-title":"Combined immune deficiency in a patient with a novel NFKB2 mutation","volume":"34","author":"Lindsley","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2019.03.010_bb0035","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1182\/blood-2014-06-578542","article-title":"Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clim.2019.03.010_bb0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12881-014-0139-9","article-title":"Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies","volume":"15","author":"Brue","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.clim.2019.03.010_bb0045","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.jaci.2014.11.038","article-title":"Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease","volume":"135","author":"Lougaris","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2019.03.010_bb0050","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005081","article-title":"NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency: a case report and review of literature","volume":"95","author":"Shi","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.clim.2019.03.010_bb0055","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1210\/jc.2017-00341","article-title":"A case report of hypoglycemia and hypogammaglobulinemia: DAVID syndrome in a patient with a novel NFKB2 mutation","volume":"102","author":"Lal","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clim.2019.03.010_bb0060","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood-2017-05-782177","article-title":"Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype","volume":"130","author":"Kuehn","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clim.2019.03.010_bb0065","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jaci.2018.01.039","article-title":"Loss of function NFKB1 variants are the most common monogenic cause of CVID in Europeans","volume":"142","author":"Tuijnenburg","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2019.03.010_bb0070","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10875-015-0198-5","article-title":"The 2015 IUIS phenotypic classification for primary immunodeficiencies","volume":"35","author":"Bousfiha","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2019.03.010_bb0075","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.4049\/jimmunol.1201807","article-title":"Identification of B cell defects using age-defined reference ranges for in vivo and in vitro B cell differentiation","volume":"190","author":"aan de Kerk","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2019.03.010_bb0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2019.03.010_bb0085","first-page":"175","article-title":"Regulation of T-cell differentiation by CD2 and CD28 accessory molecules","volume":"74","author":"de Jong","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2019.03.010_bb0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.imlet.2017.12.006","article-title":"Functional evaluation of natural killer cell cytotoxic activity in NFKB2-mutated patients","volume":"194","author":"Montin","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2019.03.010_bb0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of NF-kappaB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.clim.2019.03.010_bb0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1084\/jem.187.2.147","article-title":"Mice deficient in nuclear factor (NF)-kappa B\/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture","volume":"187","author":"Franzoso","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2019.03.010_bb0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2015.09.001","article-title":"The effects of RelB deficiency on lymphocyte development and function","volume":"65","author":"Sharfe","year":"2015","journal-title":"J. Autoimmun."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618305904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618305904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T02:45:08Z","timestamp":1565145908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661618305904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":21,"alternative-id":["S1521661618305904"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2019.03.010","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic NFKB2 variant in the ankyrin repeat domain (R635X) causes a variable antibody deficiency","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2019.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}